FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Yukari Takao

Research Profile

Anatomy

Chemicals & Drugs

Living Beings

Disorders

Genes & Molecular Sequences

Amino Acid Sequences

Concepts & Ideas

Physiology

Lymphocyte Activation

Co-author Network

Publications

TOP 3
Reiichiro Kuwahara; Ryukichi Kumashiro; Tatsuya Ide; Yuriko Koga; Teruko Hino; Akiko Hisamochi; Kazuo Tanaka; Kei Ogata; Hiroyuki Koga; Yukari Takao; Michio Sata
Predictive factors associated with the progression to hepatic failure caused by lamivudine-resistant HBV.
Shigeru Yutani; Akira Yamada; Kazumi Yoshida; Yukari Takao; Mayumi Tamura; Nobukazu Komatsu; Tatsuya Ide; Masatoshi Tanaka; Michio Sata; Kyogo Itoh
Phase I clinical study of a personalized peptide vaccination for patients infected with hepatitis C virus (HCV) 1b who failed to respond to interferon-based therapy.
Yukari Takao; Akira Yamada; Shigeru Yutani; Takeharu Ono; Yumiko Nagao; Eiji Ando; Tatsuya Ide; Kyogo Itoh; Michio Sata
Serum levels of IgG to the peptide of HCV1b core at positions 35-44 correlated with persistent infection, while levels of IgG to the peptide of NS5A at positions 2132-2140 correlated with better prognosis in HCV-infected patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Yukari Takao (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Reiichiro Kuwahara; Ryukichi Kumashiro; Tatsuya Ide; Yuriko Koga; Teruko Hino; Akiko Hisamochi; Kazuo Tanaka; Kei Ogata; Hiroyuki Koga; Yukari Takao; Michio Sata
Predictive factors associated with the progression to hepatic failure caused by lamivudine-resistant HBV.
Digestive diseases and sciences 2008;53(11):2999-3006.
2007: Shigeru Yutani; Akira Yamada; Kazumi Yoshida; Yukari Takao; Mayumi Tamura; Nobukazu Komatsu; Tatsuya Ide; Masatoshi Tanaka; Michio Sata; Kyogo Itoh
Phase I clinical study of a personalized peptide vaccination for patients infected with hepatitis C virus (HCV) 1b who failed to respond to interferon-based therapy.
Vaccine 2007;25(42):7429-35.
2007: Yukari Takao; Akira Yamada; Shigeru Yutani; Takeharu Ono; Yumiko Nagao; Eiji Ando; Tatsuya Ide; Kyogo Itoh; Michio Sata
Serum levels of IgG to the peptide of HCV1b core at positions 35-44 correlated with persistent infection, while levels of IgG to the peptide of NS5A at positions 2132-2140 correlated with better prognosis in HCV-infected patients.
Medical microbiology and immunology 2007;196(3):157-64.
2007: Satoko Matsueda; Akira Yamada; Yukari Takao; Mayumi Tamura; Nobukazu Komatsu; Shigeru Yutani; Tatsuya Ide; Michio Sata; Kyogo Itoh
A new epitope peptide derived from hepatitis C virus 1b possessing the capacity to induce cytotoxic T-lymphocytes in HCV1b-infected patients with HLA-A11, -A31, and -A33.
Cancer immunology, immunotherapy : CII 2007;56(9):1359-66.
2007: Yukari Takao; Akira Yamada; Shigeru Yutani; Hiroko Takedatsu; Takeharu Ono; Kojyu Etoh; Yi Wang; Susumu Suzuki; Tatsuya Ide; Kunitada Shimotohno; Michio Sata; Kyogo Itoh
Identification of new immunogenic peptides in conserved regions of hepatitis C virus (HCV) 1b with the potentiality to generate cytotoxic T lymphocytes in HCV1b(+) HLA-A24(+) patients.
Hepatology research : the official journal of the Japan Society of Hepatology 2007;37(3):186-95.
2006: Ryukichi Kumashiro; Yuriko Koga; Reiichiro Kuwahara; Tatsuya Ide; Teruko Hino; Kazuo Tanaka; Akiko Hisamochi; Kei Ogata; Yukari Takao; Hiroyuki Koga; Hidemi Nishida; Seiya Okuda; Teruo Sakamoto; Michio Sata
Granulocytapheresis (GCAP) for severe alcoholic hepatitis-A preliminary report.
Hepatology research : the official journal of the Japan Society of Hepatology 2006;36(3):229-36.
2006: Yi Wang; Yukari Takao; Mamoru Harada; Nobukazu Komatsu; Takeharu Ono; Michio Sata; Kyogo Itoh; Akira Yamada
Identification of hepatitis C virus (HCV) 2a-derived epitope peptides having the capacity to induce cytotoxic T lymphocytes in human leukocyte antigen-A24+ and HCV2a-infected patients.
Cellular immunology 2006;241(1):38-46.
2006: Takeharu Ono; Mamoru Harada; Akira Yamada; Masahiro Tanaka; Yukari Takao; Yasuaki Tanaka; Takashi Mine; Kikuo Sakamoto; Tadashi Nakashima; Kyogo Itoh
Antitumor effects of systemic and local immunization with a CTL-directed peptide in combination with a local injection of OK-432.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(4):1325-32.
2006: Akira Yamada; Hirohisa Yano; Yukari Takao; Takeharu Ono; Tomoko Matsumoto; Kyogo Itoh
Nonmutated self-antigen-derived cancer vaccine peptides elicit an IgE-independent but mast cell-dependent immediate-type skin reaction without systemic anaphylaxis.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(2):857-63.
2006: Yi Wang; Yukari Takao; Mamoru Harada; Shigeru Yutani; Tatsuya Ide; Michio Sata; Kyogo Itoh; Akira Yamada
New epitope peptides derived from hepatitis C virus (HCV) 2a which have the capacity to induce cytotoxic T lymphocytes in HLA-A2+ HCV-infected patients.
Microbiology and immunology 2006;50(11):857-65.
2005: Mayumi Tamura; Akira Yamada; Yukari Takao; Satoko Matsueda; Nobukazu Komatsu; Shigeru Yutani; Tatsuya Ide; Michio Sata; Kyogo Itoh
Identification of hepatitis C virus 1b-derived peptides recognized by both cellular and humoral immune systems in HCV1b(+) HLA-A24(+) patients.
Hepatology research : the official journal of the Japan Society of Hepatology 2005;32(4):227-34.
2005: Akihisa Yao; Mamoru Harada; Satoko Matsueda; Yuki Ishihara; Hiroki Shomura; Yukari Takao; Masanori Noguchi; Kei Matsuoka; Isao Hara; Sadao Kamidono; Kyogo Itoh
New epitope peptides derived from parathyroid hormone-related protein which have the capacity to induce prostate cancer-reactive cytotoxic T lymphocytes in HLA-A2+ prostate cancer patients.
The Prostate 2005;62(3):233-42.
2004: Kunie Fukuda; Yukari Takao; Yuki Miyazaki; Kyogo Itoh; Akira Yamada
New type of natural antibodies reactive to cytotoxic T lymphocyte-directed cancer vaccine peptides.
Immunobiology 2004;209(3):245-53.
2004: Yukari Takao; Akira Yamada; Shigeru Yutani; Michio Sata; Kyogo Itoh
Antibody reactive to a hepatitis C virus (HCV)-derived peptide capable of inducing HLA-A2 restricted cytotoxic T lymphocytes is detectable in a majority of HCV-infected individuals without HLA-A2 restriction.
Microbiology and immunology 2004;48(7):507-17.